{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-004576","form_type":"8-K","ticker":"AKTX","cik":"0001541157","company_name":"Akari Therapeutics Plc","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.953208+00:00","generated_at":"2026-05-28T03:15:57.210398+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Akari Therapeutics updates corporate presentation on bi-functional ADC pipeline","bullets":["Updated slide deck highlights next-generation precision bi-functional antibody drug conjugate platform.","Presentation dated January 2025 to be used in meetings with investors and potential partners.","No new financial guidance, clinical data, or operational milestones disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-004576","json":"https://secwatch.observer/filing/0000950170-25-004576.json","markdown":"https://secwatch.observer/filing/0000950170-25-004576.md","text":"https://secwatch.observer/filing/0000950170-25-004576.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1541157/000095017025004576/0000950170-25-004576-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1541157/000095017025004576/aktx-20250113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:15:57.210398+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}